Description
Betahistine Hydrochloride Dispersible Tablets
Composition:
Each uncoated dispersible tablet contains :
Betahistine Hydrochloride IP 8 mg
INDICATION & USE
• Meniere’s Disease
• Vestibular and Coordination Disturbance
• Meniere’s Disease
• Vestibular and Coordination Disturbance
Each uncoated dispersible tablet contains :
Betahistine Hydrochloride IP 8 mg
• Meniere’s Disease
• Vestibular and Coordination Disturbance
Shince Pharmaceuticals Pvt Ltd., a division of Surien Pharmaceuticals (P) Ltd., delivers excellence in pharmaceutical manufacturing and innovation worldwide.
Reviews
There are no reviews yet.